Healthcare Webinars

The All-Ireland Chromatin Consortium was established in 2021 to foster collaborations between researchers located across the whole of Ireland, promote scientific exchange, and to facilitate networking between students, postdocs, and PIs working in the field of chromatin biology. Keynote Speaker - Robin Allshire, Ph.D. - Professor of Chromosome Biology, Wellcome Trust Centre for Cell Biology, University of Edinburgh > Seminar Title: ‘Epigenetic Routes to Antifungal/Fungicide Resistance’ Prof. Robin Allshire is Professor of Chromosome Biology at University of Edinburgh and a Wellcome Trust Principal Research Fellow. His research group at the Wellcome Trust Centre for Cell Biology focuses on the epigenetic mechanisms governing the assembly of specialised domains of chromatin and their transmission through cell division. He is elected an EMBO member and Fellow of the Royal Society and Academy of Medical Sciences.

“How Legendary Changemakers Avoid Burnout? And What You Can Do to Preserve your Energy and Create your Aspired Social Impact” Another world is not only possible, she is on her way. On a quiet day, I can hear her breathing. In today's volatile world, we're witnessing historic levels of anxiety as a result of war in three continents: Europe, Africa, and the Middle East, climate catastrophes, and an unprecedented level of humanitarian crisis. Jennifer Brown writes her in article, “How Advocates for Inclusion Keep from Burning Out,” that as empathetic allies, advocates for inclusion are particularly susceptible to increased levels of anxiety as they experience the pressure to outperform themselves while representing marginalized identities and take in other people’s experiences. Advocates need to strategize their advocacy energy to prevent burnout and a systematic process to overcome burnout once identified. In this webinar, the Artist Changemaker, Shumaila Hemani, Ph.D. will offer three essential strategies to overcome burnout based on her upcoming online course: Resurgence: The Deep Listening Path to Recovering from Advocacy Burnout. Combining deep listening practices with mindfulness meditation practice and wellness, Hemani will propose we shift our approach from considering burnout as an individual-centric issue to addressing it as a systemic issue that is a by-product of the hustle culture and needs systems thinking to build resources and support within our social ecology. The participants will receive free resources, including an ebook and audio meditation to support their recovery. This webinar is relevant for any advocate who has experienced burnout during their advocacy journey.

EFAD's ESDN Diabetes - "Type 1 Diabetes and Celiac Disease in Pediatrics"

Join us for a webinar on barriers to patient partnership and equity in health research.

This webinar will discuss the importance of surveillance as an infection prevention and control practice in neonatal care. The webinar will be an opportunity to present the newly-developed NeoIPC surveillance toolkit, and to hear from experts with longstanding experience in surveillance and hospital-acquired infections. Speakers include: Aikaterini Mougkou, Expert in Antimicrobial Resistance and Healthcare-Associated Infections, European Centre for Disease Prevention and Control (ECDC) Begoña Loureiro, Cruces University Hospital; IIS Biocruces Bizkaia, Bilbao, Spain Brar Piening, Senior Physician, Institute of Hygiene and Environmental Medicine, Charité – Universitätsmedizin Berlin, Germany Christina Obiero, Researcher, KEMRI – Wellcome Trust Research Programme, Kilifi, Kenya.

To successfully treat tuberculosis it is an absolute necessity that the antimicrobial agents used reaches the site of infection in sufficient amounts. This webinar will discuss the link between drug doses and treatment outcome, the main pharmacokinetic processes, site-of-disease pharmacokinetics in pulmonary TB, combination treatment and drug-drug interactions, and the population approach using mathematical models. The target audience includes healthcare professionals, decision makers, policy makers, researchers, and the TB community.

Sexually transmitted infections (STIs) are particularly concerned about AMR because of the widespread resistance to most medicines used to treat Neisseria gonorrhoeae in many parts of the world. Other STI pathogens with potential AMR include Mycoplasma genitalium and Trichomonas vaginalis. The department of Global HIV, Hepatitis and STIs Programmes at WHO will participate in the global annual awareness campaign to raise global awareness and understanding on AMR, an important example of One Health collaboration. This year, the departments of AMR and HIV/STIs will organize a joint webinar to launch and discuss 2 WHO Technical products, that are under the Enhanced Gonococcal AMR Surveillance Programme (EGASP) umbrella. It will also be a great opportunity to bring experts, country experience, surveillance data, diagnostics and therapeutics interventions in the pipeline together in one webinar.

This live webinar will be a forum to discuss how we can move forward in ensuring pharmaceutical companies manufacture responsibly to limit the risk of AMR. The live webinar builds on examples from a new report published by the Access to Medicine Foundation in August 2023 that sets out the clear steps pharmaceutical companies can take to limit AMR risk by manufacturing responsibly. The webinar will touch upon the major changes needed to improve the landscape, as well as the roles that different stakeholders have to play, including companies, regulators, procurers and investors.

You are invited to join us for an Analyst Teach-In to explore the potential of gammaCore™ non-invasive vagus nerve stimulation (nVNS). This exclusive event, tailored for analysts and industry experts, aims to provide a comprehensive understanding of the mechanism of action and the diverse range of potential applications of non-invasive vagus nerve stimulation.

Discover an informative webinar delving into commercial manufacturing in messenger RNA (mRNA) clinical therapies, new capacity installations and unique partnering models in commercial manufacturing. mRNA and cell/gene therapies represent cutting-edge approaches in the realm of biomedicine, with a focus on innovative disease targeting and treatment. These fields are rapidly evolving, characterized by intricate landscapes, and share common challenges that demand inventive solutions for their development, scaling and eventual commercialization.In this webinar, the featured speaker will discuss new capacity installations and unique partnering models and provide key updates on their progress toward commercial manufacturing of plasmid DNA (pDNA), mRNA, lipid nanoparticle (LNP) and fill/finish.